Faculty disclosure

SEMINARS IN RADIATION ONCOLOGY Emerging Targeted Therapies in Combination With Radiation Faculty Disclosure Eric J. Bernhard, PhD Grant or research support, Merck. James A. Bonner, MD Consultant, ImClone Systems Incorporated. Paul M. Harari, MD Grant or research support, ImClone Systems, Incorporated; consultant, ImClone Systems, Incorporated, AstraZeneca. Theodore S. Lawrence, MD, PhD Research support, Pfizer Pharmaceuticals. W. Gilles McKenna, MD, PhD Grant or research support, Merck. Ruth J. Muschel, MD, PhD Grant or research support, Merck. Michael N. Needle, MD Employee, stock shareholder, ImClone Systems Incorporated. Mukesh K. Nyathi, PhD Grant or research support, Pfizer Global Research, Incorporated. Harlan W. Waksal, MD Employee, ImClone Systems Incorporated.

44

The following authors report no significant financial interest or other relationship with the manufacturer(s) of any of the products or provider(s) of any of the services included in their manuscripts or with the commercial supporters, their subsidiaries or business partners: Jennifer F. De Los Santos, MD Stephen P. Ethier, PhD Anjali K. Gupta, MD Stephen M. Hahn, MD Shyh-Min Huang, PhD Kevin P. Raisch, PhD Hoa Q. Trummell, BS Institutional Disclosure The Center for Biomedical Continuing Education (CBCE) receives educational grants from the pharmaceutical industry and other commercial sources. Companies providing grants to The CBCE include the commercial supporter(s) of this activity, as well as the manufacturer(s) of certain drugs and/or devices discussed in this activity.